A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Arteriolar vascular resistance is the primary determinant of blood pressure and is controlled by sympathetic nerves, endothelial factors (nitric oxide, endothelin), and local metabolic signals. Smooth muscle contraction shortens vessel length and reduces diameter, exponentially increasing resistance. Coordinated changes in different vascular beds redistribute blood flow according to tissue demand.
From your study of blood pressure regulation, you know that mean arterial pressure equals cardiac output multiplied by total peripheral resistance (MAP = CO × TPR). From vascular smooth muscle contraction, you understand that smooth muscle cells in vessel walls can contract or relax to change vessel diameter. Vascular tone regulation connects these concepts: arterioles — the small resistance vessels upstream of capillary beds — are where the body exerts its finest control over both systemic blood pressure and local tissue perfusion, because small changes in their diameter produce enormous changes in resistance.
The physics behind this sensitivity follows Poiseuille's law, which states that resistance is inversely proportional to the fourth power of the vessel radius (R ∝ 1/r⁴). This means that halving the radius of an arteriole increases its resistance sixteen-fold. No other cardiovascular variable has this kind of leverage. A modest 20% reduction in arteriolar diameter roughly doubles resistance through that vessel. This is why arteriolar smooth muscle is the body's primary "valve" for controlling blood flow — subtle adjustments in tone produce large hemodynamic effects.
Three categories of signals converge on arteriolar smooth muscle. Sympathetic neural control provides the baseline systemic tone: norepinephrine released from sympathetic nerve endings binds α₁-adrenergic receptors on smooth muscle, causing contraction and vasoconstriction. Most vascular beds are under tonic sympathetic innervation, meaning they are partially constricted at rest. Increasing sympathetic activity raises TPR and blood pressure; decreasing it allows vasodilation. Endothelial factors provide local modulation from the cells lining the vessel interior. When blood flow increases, the shear stress on endothelial cells stimulates production of nitric oxide (NO), which diffuses into the adjacent smooth muscle and activates guanylyl cyclase, raising cGMP and causing relaxation (vasodilation). This flow-mediated dilation matches vessel caliber to flow demand. Endothelial cells also produce endothelin-1, a potent vasoconstrictor, and prostacyclin, a vasodilator — the balance between these factors fine-tunes local tone.
Local metabolic signals provide the most direct link between tissue activity and blood flow. When a tissue increases its metabolic rate — working skeletal muscle, for instance — it consumes more O₂ and produces more CO₂, H⁺, K⁺, adenosine, and other metabolites. These substances act directly on local arteriolar smooth muscle to cause vasodilation, increasing blood flow precisely where metabolic demand is highest. This is metabolic autoregulation, and it operates independently of neural or hormonal input. The integration of all three control layers allows the cardiovascular system to perform its most impressive trick: redistribution. During exercise, sympathetic activation constricts arterioles in the splanchnic and renal beds (reducing flow to the gut and kidneys), while local metabolic vasodilation overrides sympathetic constriction in working skeletal muscle (increasing flow there). The result is that cardiac output is redirected from resting organs toward active tissues without requiring a proportional increase in total cardiac output — a coordinated reallocation managed by differential arteriolar tone across vascular beds.